Skip to main content
SpringerLink
Log in

Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution

  • Original Paper
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to assess the efficacy of TMZ on diffuse brainstem glioma, either concomitant with radiotherapy or as an adjuvant treatment after radiotherapy in children.

Methods and materials

Eighteen children (median age at diagnosis was 8.3 years) meet the following criteria: (1) newly diagnosed diffuse brainstem glioma; (2) aged less than 18 years old, which were treated with TMZ at Taipei Veterans General Hospital from January 2004 to December 2008. They were divided into two groups according to treatment modalities: a radiotherapy alone followed by adjuvant TMZ (RT+TMZ) group received conventional radiation after initial diagnosis, and a concomitant chemoradiotherapy followed by adjuvant TMZ (CCRT+TMZ) group received concurrent chemotherapy during radiation with TMZ (75 mg/M²/day). After completion of the radiotherapy, TMZ (150 mg/M²) was administered once per day for five consecutive days for all enrolled patients in each 28-day cycle. We evaluated the progression-free survival in both groups of patients.

Results

There were 10 patients in RT+TMZ group and eight in CCRT+TMZ group. All patients experienced progression of disease. Twelve patients (75%) died, and all deaths were attributed to the disease progression. The median progression-free survival (PFS) was 7.4 months for the RT+TMZ group and 6.4 months for the CCRT+TMZ group. The 6-month and 1-year PFS in the RT+TMZ group were 70% (SD 14%) and 30% (SD 14%), respectively, and in the CCRT+TMZ group, they were 50% (SD 17%) and 0%, respectively. The log-rank test in PFS between the two groups was not statistically significant.

Conclusions

In this study, CCRT with TMZ followed by adjuvant TMZ did not result in a better outcome when compared with RT alone followed by adjuvant TMZ. In addition, TMZ either as adjuvant therapy or as CCRT did not improve the prognosis of the patients with newly diagnosed diffuse brainstem glioma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Reference

  1. Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 33:1026–1029

    Article  CAS  PubMed  Google Scholar 

  2. Beauchesne P (2002) Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20:3180–3181

    PubMed  Google Scholar 

  3. Bouffet E, Raquin M, Doz F, Gentet JC, Rodary C, Demeocq F, Chastagner P, Lutz P, Hartmann O, Kalifa C (2000) Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 88:685–692

    Article  CAS  PubMed  Google Scholar 

  4. Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, Stewart C, Krasin MJ, Gajjar A (2005) Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer 103:133–139

    Article  CAS  PubMed  Google Scholar 

  5. Cohen K, Heideman R, Zhou T, Holmes E, Pollack I (2007) Abstracts for the Twelfth Annual Meeting of the Society for Neuro-Oncology: Chemoradiotherapy with temozolomide chemoradiotherapy with temozolomide in the treatment of diffuse intrinsic pontine gliomas of childhood: result of the children’s oncology group (COG) ACNS0126 trial. Neuro Oncol 9:539

    Google Scholar 

  6. Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L, Wannenmacher MM, Debus J (2005) Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Strahlenther Onkol 181:372–377

    Article  PubMed  Google Scholar 

  7. Drogosiewicz M, Perek-Polnik M, Filipek I, Mbowska-Baginska B, Jurkiewicz E, Daszkiewicz P, Perek D (2006) Treatment results of children and adolescents with brain stem tumours. Own experiences. Med Wieku Rozwoj 10:687–698

    PubMed  Google Scholar 

  8. Eberlein KH, Nagel B, Franz K, Imhoff D, Seifert V, Boettcher HD, Mose S (2006) Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas. Anticancer Res 26:4959–4964

    CAS  PubMed  Google Scholar 

  9. Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ (1996) Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 24:9–23

    Article  CAS  PubMed  Google Scholar 

  10. Fisher PG, Breiter SN, Carson BS, Wharam MD, Williams JA, Weingart JD, Foer DR, Goldthwaite PT, Tihan T, Burger PC (2000) A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities. Cancer 89:1569–1576

    Article  CAS  PubMed  Google Scholar 

  11. Freeman CR, Farmer JP (1998) Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys 40:265–271

    CAS  PubMed  Google Scholar 

  12. Freeman CR, Perilongo G (1999) Chemotherapy for brain stem gliomas. Childs Nerv Syst 15:545–553

    Article  CAS  PubMed  Google Scholar 

  13. Friedman HS, McLendon RE, Kerby T, Dugan M, Bigner SH, Henry AJ, Ashley DM, Krischer J, Lovell S, Rasheed K, Marchev F, Seman AJ, Cokgor I, Rich J, Stewart E, Colvin OM, Provenzale JM, Bigner DD, Haglund MM, Friedman AH, Modrich PL (1998) DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol 16:3851–3857

    CAS  PubMed  Google Scholar 

  14. Guillamo JS, Monjour A, Taillandier L, Devaux B, Varlet P, Haie-Meder C, Defer GL, Maison P, Mazeron JJ, Cornu P, Delattre JY (2001) Brainstem gliomas in adults: prognostic factors and classification. Brain 124:2528–2539

    Article  CAS  PubMed  Google Scholar 

  15. Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241–248

    Article  PubMed  Google Scholar 

  16. Jakacki RI, Jamison C, Mathews VP, Heilman DK, Dropcho E, Cornetta K, Macdonald DR, Williams DA (1998) Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. Med Pediatr Oncol 31:483–490

    Article  CAS  PubMed  Google Scholar 

  17. Kondo S, Kondo Y, Li G, Silverman RH, Cowell JK (1998) Targeted therapy of human malignant glioma in a mouse model by 2–5A antisense directed against telomerase RNA. Oncogene 16:3323–3330

    Article  CAS  PubMed  Google Scholar 

  18. Lanzetta G, Campanella C, Rozzi A, Nappa M, Costa A, Fedele F, Innocenzi G, Gagliardi FM, Salvati M, Minniti G, Frati A, Frati L, Vecchione A (2003) Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Anticancer Res 23:5159–5164

    CAS  PubMed  Google Scholar 

  19. Lashford LS, Thiesse P, Jouvet A, Jaspan T, Couanet D, Griffiths PD, Doz F, Ironside J, Robson K, Hobson R, Dugan M, Pearson AD, Vassal G, Frappaz D (2002) Temozolomide in malignant gliomas of childhood: a United Kingdom Children’s Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20:4684–4691

    Article  CAS  PubMed  Google Scholar 

  20. Laske DW, Youle RJ, Oldfield EH (1997) Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3:1362–1368

    Article  CAS  PubMed  Google Scholar 

  21. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277–1280

    CAS  PubMed  Google Scholar 

  22. Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, Kovnar E, Burger P, Sanford RA, Kepner J, Friedman H, Kun LE (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43:959–964

    Article  CAS  PubMed  Google Scholar 

  23. Maria BL, Rehder K, Eskin TA, Hamed LM, Fennell EB, Quisling RG, Mickle JP, Marcus RB Jr, Drane WE, Mendenhall NP (1993) Brainstem glioma: I. Pathology, clinical features, and therapy. J Child Neurol 8:112–128

    Article  CAS  PubMed  Google Scholar 

  24. Massimino M, Spreafico F, Biassoni V, Simonetti F, Riva D, Trecate G, Giombini S, Poggi G, Pecori E, Pignoli E, Casanova M, Ferrari A, Meazza C, Luksch R, Terenziani M, Cefalo G, Podda M, Polastri D, Clerici CA, Fossati-Bellani F, Gandola L (2008) Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 87:355–361

    Article  CAS  PubMed  Google Scholar 

  25. Packer RJ (1996) Brain tumors in children. Curr Opin Pediatr 8:549–557

    Article  CAS  PubMed  Google Scholar 

  26. Packer RJ (1999) Alternative treatments for childhood brain tumors. Childs Nerv Syst 15:789–794

    Article  CAS  PubMed  Google Scholar 

  27. Salmaggi A, Fariselli L, Milanesi I, Lamperti E, Silvani A, Bizzi A, Maccagnano E, Trevisan E, Laguzzi E, Ruda R, Boiardi A, Soffietti R (2008) Natural history and management of brainstem gliomas in adults. A retrospective Italian study. J Neurol 255:171–177

    Article  CAS  PubMed  Google Scholar 

  28. Sirachainan N, Pakakasama S, Visudithbhan A, Chiamchanya S, Tuntiyatorn L, Dhanachai M, Laothamatas J, Hongeng S (2008) Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma. Neuro Oncol 10:577–582

    Article  CAS  PubMed  Google Scholar 

  29. Tsang LL, Farmer PB, Gescher A, Slack JA (1990) Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity. Cancer Chemother Pharmacol 26:429–436

    Article  CAS  PubMed  Google Scholar 

  30. van Rijn J, Heimans JJ, van den Berg J, van der Valk P, Slotman BJ (2000) Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int J Radiat Oncol Biol Phys 47:779–784

    Article  PubMed  Google Scholar 

  31. Wagner S, Warmuth-Metz M, Emser A, Gnekow AK, Strater R, Rutkowski S, Jorch N, Schmid HJ, Berthold F, Graf N, Kortmann RD, Pietsch T, Sorensen N, Peters O, Wolff JE (2006) Treatment options in childhood pontine gliomas. J Neurooncol 79:281–287

    Article  PubMed  Google Scholar 

  32. Walker DA, Punt JA, Sokal M (1999) Clinical management of brain stem glioma. Arch Dis Child 80:558–564

    Article  CAS  PubMed  Google Scholar 

  33. Wedge SR, Porteous JK, Glaser MG, Marcus K, Newlands ES (1997) In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs 8:92–97

    Article  CAS  PubMed  Google Scholar 

  34. Wong TT, Ho DM, Chang KP, Yen SH, Guo WY, Chang FC, Liang ML, Pan HC, Chung WY (2005) Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975–2004). Cancer 104:2156–2167

    Article  PubMed  Google Scholar 

  35. Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, Albright R, Olson J, Chang SM, O’Neill AM, Friedman AH, Bruner J, Yue N, Dugan M, Zaknoen S, Levin VA (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 17:2762–2771

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

  1. Departments of Pediatrics, Kuang-Tien General Hospital, Taichung, Taiwan

    Kuo-Liang Chiang

  2. Department of Pediatrics, Taipei Veterans General Hospital, No. 201, Sec 2, Shih-Pai Road, 11217, Taipei, Taiwan

    Kuo-Liang Chiang, Kai-Ping Chang & Ting-Rong Hsu

  3. Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan

    Yi-Yen Lee & Tai-Tong Wong

  4. Cancer Center, Taipei Veterans General Hospital, Taipei, Taiwan

    Pin-I Huang & Yi-Wei Chen

  5. Radiology Department, Taipei Veterans General Hospital, Taipei, Taiwan

    Feng-Chi Chang

  6. National Yang-Ming University School of Medicine, Taipei, Taiwan

    Yi-Yen Lee, Pin-I Huang, Ting-Rong Hsu, Yi-Wei Chen, Feng-Chi Chang & Tai-Tong Wong

Authors
  1. Kuo-Liang Chiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai-Ping Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yi-Yen Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pin-I Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ting-Rong Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yi-Wei Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Feng-Chi Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tai-Tong Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kai-Ping Chang.

Additional information

Kuo-Liang Chiang and Kai-Ping Chang contributed equally to this paper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiang, KL., Chang, KP., Lee, YY. et al. Role of temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: experience at a single institution. Childs Nerv Syst 26, 1035–1041 (2010). https://doi.org/10.1007/s00381-010-1106-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-010-1106-1

Keywords

Search

Navigation